Report Finds Meth-Like Substance in Workout Supplement - News, Sports and Weather

Report Finds Meth-Like Substance in Workout Supplement

Posted: Updated:

According to a new study from the Harvard Medical School and the National Institute for Public Health and the Environment, a popular workout supplement could contain properties similar to meth.

The pre-workout powder, known as Craze, tested positive for an analog of methamphetamine, but the ingredient is not listed on the powder's packaging.

Even with all the publicity surrounding the controversial study, Craze is still easily available to be purchased in Great Falls.

Some retailers of these types of supplements, such as Walmart and, have pulled Craze off their shelves in light of the information.

"They discovered amphetamine traces. Athletes from all over the world have been disqualified from sporting events because they had taken Craze without knowing that the amphetamine was in the substance. Now these athletes have been banned because of it," said Dr. Paul Johnson, MD from Benefis Health System.

Driven Sports, the brand behind Craze, has released statements on their web site defending the product.  They claim these studies are inaccurate and their own studies of the powder showed no traces of methamphetamines in the product.

However, the maker of Craze, Matt Cahill, is currently facing charges in California for putting other risky products on the market.

The Food and Drug Administration is not involved in regulating these products, but recently U.S. Senator Richard Durbin of Illinois brought up a new bill that would regulate these unknown and possibly dangerous supplements.

In the meantime, Johnson had this advice for those thinking about taking the supplement.

"Read the labels, do some research, and make sure [the supplement] doesn't have any illegal substance in it."

Powered by WorldNow


  • Sports
  • Community

  • Community
  • Powered by WorldNow
    All content © Copyright 2000 - 2014 WorldNow and Max Media. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.